Summit Trail Advisors, LLC Intercept Pharmaceuticals, Inc. Transaction History

Summit Trail Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$88.49 - $127.55 $35,396 - $51,020	-400 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$60.0 - $85.67 $2.86 Million - $4.09 Million	-47,716 Reduced 99.17%	400 $34,000
Q1 2018 May 21, 2018	BUY	$52.72 - $67.25 $2.51 Million - $3.21 Million	47,688 Added 11142.06%	48,116 $48,000
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $24,909 - $31,141	428	428 $26,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.